Clinuvel Pharmaceuticals Ltd
ASX:CUV
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Price:
15.39 AUD
-0.39%
Market Closed
Updated:
May 20, 2024
Clinuvel Pharmaceuticals Ltd
EPS (Diluted)
|
Clinuvel Pharmaceuticals Ltd
EPS (Diluted) Peer Comparison
Comparables:
IMM
MSB
CSL
TLX
PYC
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Immutep Ltd
ASX:IMM
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
Mesoblast Ltd
ASX:MSB
|
EPS (Diluted)
$0
|
CAGR 3-Years
21%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
EPS (Diluted)
$5
|
CAGR 3-Years
-4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Clinuvel Pharmaceuticals Ltd's EPS (Diluted)?
EPS (Diluted)
0.6
AUD
0.6
AUD
Based on the financial report for Dec 31, 2023, Clinuvel Pharmaceuticals Ltd's EPS (Diluted) amounts to 0.6 AUD.
What is Clinuvel Pharmaceuticals Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
12%
12%
Over the last year, the EPS (Diluted) growth was 16%. The average annual EPS (Diluted) growth rates for Clinuvel Pharmaceuticals Ltd have been 10% over the past three years , 12% over the past five years .
You don't have any saved screeners yet
